Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL

Guido Lancman; Amir Steinberg; Janice Gabrilove

Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL

Guido Lancman, Amir Steinberg, Janice Gabrilove

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU^1-3, but also seen with docetaxel^4,5, fotemustine⁶, and vinorelbine⁷. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU¹. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	International Journal of Hematology-Oncology and Stem Cell Research
Volume	12
Issue number	1
State	Published - 2018

Keywords

Chemotherapy
DLBCL
R- CHOP
SSH
Serpentine supravenous hyperpigmentation

Cite this

@article{02efbc7a1fb147ecb116c2e0d1a603af,

title = "Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL",

abstract = "Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.",

keywords = "Chemotherapy, DLBCL, R- CHOP, SSH, Serpentine supravenous hyperpigmentation",

author = "Guido Lancman and Amir Steinberg and Janice Gabrilove",

year = "2018",

language = "English",

volume = "12",

pages = "1--3",

journal = "International Journal of Hematology-Oncology and Stem Cell Research",

issn = "1735-1243",

publisher = "Tehran University of Medical Sciences",

number = "1",

}

TY - JOUR

T1 - Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL

AU - Lancman, Guido

AU - Steinberg, Amir

AU - Gabrilove, Janice

PY - 2018

Y1 - 2018

N2 - Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.

AB - Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU1-3, but also seen with docetaxel4,5, fotemustine6, and vinorelbine7. It consists of a marked hyperpigmentation along the superficial network of veins proximal to the chemotherapy infusion site and was originally described in a 1976 case report in association with 5-FU1. Here, for the first time, we report SSH in association with R-CHOP chemotherapy.

KW - Chemotherapy

KW - DLBCL

KW - R- CHOP

KW - SSH

KW - Serpentine supravenous hyperpigmentation

UR - http://www.scopus.com/inward/record.url?scp=85041714332&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85041714332

SN - 1735-1243

VL - 12

SP - 1

EP - 3

JO - International Journal of Hematology-Oncology and Stem Cell Research

JF - International Journal of Hematology-Oncology and Stem Cell Research

IS - 1

ER -

Serpentine supravenous hyperpigmentation in an HIV patient receiving R-CHOP for DLBCL

Abstract

Keywords

Fingerprint

Cite this